| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.007 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.007 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.08 | 0.009 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |